Changed date for the publishing of AddLife´s Year-end Report for 2018

Due to the acquisition of Austrian Biomedica Medizinprodukte GmbH the board of directors of AddLife has decided to postpone the date of the publishing of the Year-end Report for 2018 from 5 February 2019 to 12 February 2019.

The Year-end Report for 2018 will be published on 12 February 2019, at 08.00 a.m. (CET) and a conference call will be hosted at 10.00 a.m. (CET).

Stockholm, 26 November, 2018

AddLife AB (publ)

For more information, please contact:
Kristina Willgård, CEO, AddLife AB, kristina.willgard@add.life +46 (0)70 510 12 23,
Martin Almgren, CFO, AddLife AB, martin.almgren@add.life +46 (0)70 228 15 45,
www.add.life

AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sector, mainly in the Nordic region. AddLife has about 600 employees in some 30 operating subsidiaries. The group currently has net sales of around SEK 2.5 billion. AddLife shares are listed on NASDAQ Stockholm.

The information in this press release is of the nature that AddLife AB (publ) is obliged to make public pursuant to Nasdaq First Norths rulebook for issuers. The information was submitted for publication, through the agency of the contact persons set out above, at 26 November 2018 at 14:10 p.m (CET).